These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 30786742)

  • 1. Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report.
    van der Vorst EPC; Mandl M; Müller M; Neideck C; Jansen Y; Hristov M; Gencer S; Peters LJF; Meiler S; Feld M; Geiselhöringer AL; de Jong RJ; Ohnmacht C; Noels H; Soehnlein O; Drechsler M; Weber C; Döring Y
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):685-693. PubMed ID: 30786742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
    Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
    Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice.
    Macritchie N; Grassia G; Sabir SR; Maddaluno M; Welsh P; Sattar N; Ialenti A; Kurowska-Stolarska M; McInnes IB; Brewer JM; Garside P; Maffia P
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2569-79. PubMed ID: 22936340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia.
    Bondue B; Vosters O; de Nadai P; Glineur S; De Henau O; Luangsay S; Van Gool F; Communi D; De Vuyst P; Desmecht D; Parmentier M
    PLoS Pathog; 2011 Nov; 7(11):e1002358. PubMed ID: 22072972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.
    Wan W; Liu Q; Lionakis MS; Marino AP; Anderson SA; Swamydas M; Murphy PM
    Cardiovasc Res; 2015 Jun; 106(3):478-87. PubMed ID: 25858253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD70 limits atherosclerosis and promotes macrophage function.
    Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
    Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and metabolic reprogramming induce macrophage pro-inflammatory phenotype switch and atherosclerosis progression in aging.
    Vendrov AE; Lozhkin A; Hayami T; Levin J; Silveira Fernandes Chamon J; Abdel-Latif A; Runge MS; Madamanchi NR
    Front Immunol; 2024; 15():1410832. PubMed ID: 38975335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
    Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
    Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
    Ditiatkovski M; Toh BH; Bobik A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2337-44. PubMed ID: 16873730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model.
    Luangsay S; Wittamer V; Bondue B; De Henau O; Rouger L; Brait M; Franssen JD; de Nadai P; Huaux F; Parmentier M
    J Immunol; 2009 Nov; 183(10):6489-99. PubMed ID: 19841182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.
    Sato K; Yoshizawa H; Seki T; Shirai R; Yamashita T; Okano T; Shibata K; Wakamatsu MJ; Mori Y; Morita T; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
    Clin Sci (Lond); 2019 Aug; 133(16):1779-1796. PubMed ID: 31399499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.